Nasdaq

Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019

15-03-2019

BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31st Annual ROTH Conference March 19, 2019. The Conference is taking place March 17th - March 19th, 2019 at the Ritz Carlton Laguna Niguel, California.

Jason Grenfell-Gardner, Chief Executive Officer of Teligent, Inc., will present on Tuesday March 19th at 1:30 p.m. PT. 

The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com 


Interstitiel escarre

Interstitiel hydrot boostclosure

* Temps de fermeture de l’ulcère avec HydroTac® : moins de 15 semaines alors que les données de la littérature montrent que 40-60% des ulcères nécessitent 20 à 24 semaines pour cicatriser. (1) Mikosiński, J. et al. Clinical assessment of a foam dressing containing growth factor-enhancing hydrated polyurethanes. J Wound Care.2018;27(9):608-18. HydroTac® : DM de classe IIb – Fabricant : PAUL HARTMANN AG – Organisme notifié : CE 0123. Lire attentivement les instructions figurant dans la notice (et/ou sur l’étiquetage). Remboursé par les organismes d’assurance maladie : consultez les modalités sur le site www.ameli.fr. Réf : 14122018. Date de création : Décembre 2018